Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed a government funding lapse notice and Revision: v3.4.1.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedShow glossary toggle added; UI legends explain color-coded additions (green) and deletions (red), and the revision label updated to v3.4.0. No core content changes occurred; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check64 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the page history; these are administrative updates and do not affect the study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe revision history shows the addition of v3.3.2 and the removal of v3.3.1 for the page. This reflects an internal site update to the Record History view.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.